Experimental treatment significantly slows progression of fatal brain disease in women, study finds

Researchers at Tel Aviv University found that the drug Davunetide significantly slowed disease progression in women with progressive supranuclear palsy (PSP), though it showed no effect in men. The study highlights the importance of sex-specific clinical trials in neurodegenerative disease research.